U.S. Transportation Stock News

If you have been tracking Intuitive Surgical, you might be wondering if this is a smart time to buy in, hold steady, or wait for a better price. With its robotic-assisted surgery technology, the company has long commanded investor attention, but recent price swings may have left some feeling uncertain. In the last three months alone, Intuitive Surgical’s stock has given up about 11%. If you zoom out to three or five years, the returns have been stellar, up over 100% in both periods. Clearly,...

If you have been following ConocoPhillips (COP), you probably noticed the latest action after the company released its second-quarter earnings. While sales and revenue climbed over last year, net income and earnings per share dipped, leaving some investors reassessing what this mixed performance means for their portfolios. At the same time, management reaffirmed production guidance for the full year, which has nudged confidence that operational targets are on steady ground. In addition,...

Thinking about whether to buy, hold, or sell AppLovin stock right now? You're not alone. With AppLovin’s price jumping nearly 18% over the past month and a massive 363% surge in the past year, plenty of investors are trying to figure out what is driving this momentum. While past returns never guarantee future results, such strong performance can change how people perceive the company’s risk and growth potential. AppLovin has benefited from surging demand in the mobile advertising and app...

Sirius XM Holdings (SIRI) has been on the radar lately after its stock price dipped nearly 3% in a single day, sparking fresh debate among shareholders about what is driving the latest moves. While there is not one headline-grabbing event behind this shift, the recent drop is hard to ignore for anyone following the satellite radio space. Whether you are holding shares or thinking about getting in, this price action is a good reminder to revisit what is happening under the hood at Sirius...

Franklin Wireless Corp.'s ( NASDAQ:FKWL ) price-to-sales (or "P/S") ratio of 1.1x might make it look like a buy right...

Blackstone (BX) shares are getting a fresh look from investors this week after the stock slipped 1.7% in the latest session. While there was no major news moving the markets today, any sharp pullback in a widely held stock like Blackstone is sure to prompt questions. Is this an early sign of shifting sentiment, or just a routine blip that opens up an interesting pricing discussion? Over the last year, Blackstone’s stock has delivered a 25% total return, supported by healthy annual revenue and...

NextEra Energy (NEE) has seen its share price catch the attention of investors lately, especially after a swing of over 13% higher during the past three months. With little in the way of headline-grabbing news or major announcements, some might wonder if these recent moves are signalling a change in how investors are valuing this energy giant. As the market’s mood shifts week by week, identifying the reasons a stock like NextEra Energy gains traction without a clear catalyst can be tricky...

LENZ Therapeutics recently received FDA approval for its Vizz eye drops to treat presbyopia in adults, a key regulatory milestone for the company. This approval sets LENZ Therapeutics up for an early-mover advantage in the competitive presbyopia treatment market. We’ll explore how initial FDA approval for Vizz eye drops could reshape LENZ Therapeutics’ overall investment thesis. The end of cancer? These 26 emerging AI stocks are developing tech that will allow early identification of life...

In August 2025, Akero Therapeutics announced the publication of final 96-week results from its Phase 2b HARMONY trial in The Lancet, showing that efruxifermin improved both fibrosis and metabolic health in adults with metabolic dysfunction-associated steatohepatitis (MASH) and moderate or advanced fibrosis. The data suggest efruxifermin may address multiple risk factors in MASH, including cardiovascular risks, highlighting its potential as a comprehensive therapy currently undergoing Phase 3...

Thinking about what to do with Coca-Cola stock? You are not alone. With its status as one of the most recognizable consumer brands in the world, Coca-Cola often finds itself at the crossroads of value and potential. Lately, the stock price has offered some signals that are worth a closer look. Over the last month, shares have inched up nearly 0.9%, and year to date, KO is up about 14.3%. While the last quarter saw a minor dip, this was against a fairly stable broader market mood and growing...

Rhythm Pharmaceuticals (RYTM) just received a significant decision from the FDA, as their supplemental New Drug Application for setmelanotide was not only accepted for filing but also granted Priority Review status. This indicates that the agency sees potential for the medication to address an urgent, unmet need for people dealing with acquired hypothalamic obesity. Investors familiar with Rhythm know setmelanotide already has approvals for rare genetic obesity disorders. This proposed...

Cheniere Energy Partners (NYSE:CQP) just delivered a double dose of updates that will catch the eye of anyone following the stock. The company reported its latest second quarter and half-year results, showing another jump in revenue over last year, even as profits ticked down a bit. Alongside earnings, Cheniere also reaffirmed its 2025 distribution guidance, reassuring those who rely on its steady payouts. For income investors, that kind of clarity can make a big difference when planning out...

DENTSPLY SIRONA Inc. announced its second quarter 2025 results in August, revealing sales of US$936 million and a net loss of US$45 million, with management reaffirming its full-year sales guidance of US$3.60 billion to US$3.70 billion amid continued industry headwinds. An interesting aspect is the board’s decision to maintain its dividend at US$0.16 per share, contrasting with ongoing revenue pressure and signaling a commitment to shareholder returns despite financial challenges. We’ll...

Thinking about investing in Vulcan Materials, or maybe deciding whether to hold on to your shares? You are in good company. Vulcan Materials has caught the attention of market watchers, especially after its stock price shrugged off some short-term dips and delivered an impressive 16.4% return over the past year. That is a performance hard to ignore, especially when you look at its nearly 143% total return over five years. Recent months have shown a blend of resilience and optimism, with the...

If you have your eye on Live Nation Entertainment stock, you are not alone. With concerts and live experiences roaring back, investors have seen the company’s share price climb an impressive 25% so far this year and over 67% over the past twelve months. That kind of run naturally raises the question: does LYV have more room to run, or is the market already pricing in all that potential? Digging a bit deeper, LYV’s journey has been anything but boring. In just the past three months, the stock...

NasdaqGS:JD 1 Year Share Price vs Fair Value Explore JD.com's Fair Values from the Community and select yours JD.com...

Thinking about what to do with Pony AI stock? You are not alone. As one of the more intriguing names in the autonomous vehicle sector, Pony AI has experienced its fair share of twists and turns recently. For traders and long-term investors alike, the past few months have brought some big price swings that demand a closer look. Let us start with the numbers. After a dip of nearly 28% over the past 90 days, Pony AI has rebounded with a 15.6% climb over the last month. That recent rally, coupled...

Earlier this month, Duke Energy announced it submitted the final license application to the Federal Energy Regulatory Commission for its Bad Creek Pumped Storage Hydroelectric Station in South Carolina, seeking to extend the plant’s operations for another 50 years and add 320 megawatts of carbon-free energy following recent upgrades. This major licensing step signals Duke Energy's continued investment in large-scale grid storage and emissions-free generation as it supports growing regional...

BKV Corporation recently reported strong second quarter financial results, moving from a net loss to net income of US$104.57 million, and increased its 2025 production guidance to a midpoint of 800 million cubic feet equivalent per day while maintaining its original capital spending range. This operational update comes ahead of the anticipated Bedrock acquisition, and highlights improved efficiency given the increased output on unchanged capital plans. We'll explore how maintaining capital...

Earlier this month, Autohome announced it had extended its share repurchase plan to December 31, 2025, after buying back 5,422,647 shares (4.5% of shares outstanding) for a total of US$144.33 million since the September 2024 announcement. This move underscores management’s ongoing confidence in the business and provides additional support for shareholders as the company continues its capital return efforts. We’ll explore how the extension of Autohome’s buyback program influences its...

PBF Energy recently announced that Joseph Marino will become Chief Financial Officer, effective October 1, 2025, following the retirement of current CFO Karen B. Davis, who will subsequently rejoin the Board of Directors. This internal leadership transition marks a return for a seasoned finance executive to the Board and highlights the company's focus on continuity and experienced management. We'll examine how the promotion of Joseph Marino to CFO may influence PBF Energy's investment...

If you have been eyeing Northrop Grumman, you are in good company. The stock has been grabbing attention for its impressive run over the last few months. With a year-to-date return of about 27% and a 90-day gain of 25%, it is fair to ask if the market is finally catching up to Northrop's prospects, or if there is more room to grow, or perhaps risks to consider. Recent news has fueled the conversation around NOC. The company announced plans to quadruple its chip output by 2030, signaling...

Thinking about whether to hold, buy, or sell Oracle? You are in good company. Oracle’s stock has experienced considerable volatility, with short-term dips but significant growth over the past year. In just the last 90 days, shares are up almost 50%, and that one-year return is nearly 70%. Clearly, something notable is happening behind the scenes. What is driving these swings? For one, Oracle continues to secure major deals and draw investment headlines. Over the past month, news broke that...

Performance Food Group reported its fourth quarter and full-year 2025 results, delivering US$16.94 billion in quarterly sales and offering guidance for fiscal 2026 sales between US$67 billion and US$68 billion. Despite higher sales, the company posted a year-over-year decline in both quarterly and full-year net income, prompting management to highlight continued efficiency initiatives and disciplined capital allocation, including share buybacks and potential acquisitions. We'll explore how...